Scleroderma News

Discover more: https://bit.ly/4A8ARZt

Vitamin B3 may reduce abnormalities in the tiny blood vessels of people with scleroderma who have Raynaud’s phenomenon, a study suggests.

Explore the details: https://bit.ly/4y1zeuG

John Stamos will receive the Bob Saget Legacy Award for his longtime support of scleroderma research at an October SRF fundraiser.

Explore the details: https://bit.ly/4xRXcrU

Treatment guidelines for systemic scleroderma (SSc) have evolved with advances in scientific understanding, a study shows.

Get the scoop: https://bit.ly/4g9LXnG

Blood protein KL-6 may help identify people with SSc-ILD at greater risk of short-term lung function decline.

Explore the details: https://bit.ly/4wBdyED

People with SSc who don’t show the scleroderma pattern of small blood vessel damage may have a milder course of the disease, per a study.

Discover more: https://bit.ly/4wrS1y5

A wireless sensor may help track scleroderma-related skin stiffness at home, but larger studies are needed to validate its use.

Discover more: https://bit.ly/45uLd7Q

A new scleroderma survey seeks patient experiences from adults to better understand disease burden, unmet needs, and research priorities.

Explore the details: https://bit.ly/4ice9Zy

Scleroderma was added to the NIH Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases project.

Explore the details: https://bit.ly/4bRVLS0

An off-the-shelf cell therapy in clinical testing in a large trial in the U.S. and Europe has shown early promise as a scleroderma treatment.

Explore the details: https://bit.ly/4gg7iMi

A clinical trial from Indero and the World Scleroderma Foundation will evaluate treatments at the earliest stages of systemic sclerosis.